Ready-made ETF portfolios built for real investor needs. Explore now →

Advertisement
Advertisement

LGHTvsFXHETF Comparison

ETF 1
LGHT

Langar Global HealthTech ETF

This fund is part of
Healthcare Technology
-1.69%
VS
ETF 2
FXH

First Trust Health Care AlphaDEX Fund ETF

This fund is part of
US Health Care
-0.92%

Langar Global HealthTech ETF (LGHT) belongs to the Healthcare Technology segment. First Trust Health Care AlphaDEX Fund ETF (FXH) is part of the US Health Care segment. Both ETFs have the same top 1 sector exposures: Healthcare. LGHT is more expensive with a Total Expense Ratio (TER) of 0.85%, versus 0.61% for FXH. LGHT is up 10.05% year-to-date (YTD) with -$1M in YTD flows. FXH performs better with 18.78% YTD performance, and +$33M in YTD flows. Run a side-by-side ETF comparison of LGHT and FXH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

LGHT vs FXH performance and flow charts

Performance

0510%Sep 15Sep 22Sep 29Oct 6Oct 13

Cumulative Flows

-30 M-20 M-10 M0 M10 MSep 15Sep 22Sep 29Oct 6Oct 13

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 10/16/2026
1M3MYTD1Y3Y5Y
Perf.
LGHT
FXH
+11.26%+2.90%
+25.73%+9.93%
+10.05%+18.78%
+8.74%+22.08%
n/a+41.84%
n/a+17.25%
Flows
LGHT
FXH
--$32M
-$86K+$33M
-$1M+$33M
-$2M+$39M
--$482M
--$464M
Volatility and drawdown
3M1Y3Y5Y
Volatility
LGHT
FXH
+37.64%+14.95%
+26.13%+15.45%
n/a+15.67%
n/a+16.92%
Max drawdown
LGHT
FXH
-8.50%-4.82%
-25.58%-12.07%
n/a-17.66%
n/a-27.47%
Max drawdown duration
LGHT
FXH
40d51d
346d168d
n/a395d
n/a1638d
Trading data

Create an account to view trading data

Join for free
LGHT
FXH
Last sale
10/16/2026 at 1:30 PM
$132.43
Previous close
10/15/2026
$134.50
Consolidated volume
10/15/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of September 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

LGHT
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
LGHT
FXH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Main metrics
Last update 10/16/2026 at 1:30 PM
Live
Closed
LGHT
FXH
Last price
–
$132.43
1D performance
–
-1.54%
AuM$2.53 M$1.14 B
E/R0.85%0.61%
Characteristics
LGHT
FXH
Management strategyActivePassive
ProviderLangar Investment ManagementFirst Trust
Benchmark-StrataQuant Health Care Index
N° of holdings3072
Asset class-Equities
Trailing 12m distribution yield
Join
Join
Inception dateJanuary 10, 2024May 8, 2007
ESGYesNo
Advertisement
Exposure

Countries

LGHT
USA
83.8%
Other
16.2%
FXH
USA
93.13%
Other
6.87%

Sectors

LGHT
Healthcare
98.54%
Other
1.46%
FXH
Healthcare
98.23%
Other
1.77%
Advertisement

Diversification

LGHT

Total weight of top 15 holdings out of 15

90.56%
FXH

Total weight of top 15 holdings out of 15

35.47%

Top 15 holdings

Data as of August 31, 2026
LGHT
Moderna, Inc.
13.79%
Veeva Systems, Inc.
9.69%
ResMed, Inc.
9.41%
IQVIA Holdings, Inc.
8.20%
Intuitive Surgical, Inc.
7.88%
GE Healthcare Technologies, Inc.
6.77%
DexCom, Inc.
5.92%
Koninklijke Philips NV
4.94%
Siemens Healthineers AG
4.72%
Sonova Holding AG
3.82%
Insulet Corp.
3.61%
Zimmer Biomet Holdings, Inc.
3.21%
Align Technology, Inc.
3.15%
iRhythm Holdings, Inc.
2.91%
Doximity, Inc.
2.54%
FXH
Regeneron Pharmaceuticals, Inc.
2.86%
Pfizer Inc.
2.56%
Natera, Inc.
2.55%
Solventum Corp.
2.55%
Zimmer Biomet Holdings, Inc.
2.49%
Universal Health Services, Inc.
2.48%
Boston Scientific Corp.
2.43%
Guardant Health, Inc.
2.37%
Tenet Healthcare Corp.
2.29%
Halozyme Therapeutics, Inc.
2.22%
The Cigna Group
2.22%
Globus Medical, Inc.
2.20%
Centene Corp.
2.20%
Corcept Therapeutics, Inc.
2.10%
Encompass Health Corp.
1.95%
Frequently asked questions about LGHT and FXH

How have the LGHT and FXH ETFs performed in 2026?

As of October 16, 2026, LGHT is up 10.05% year-to-date (YTD), while FXH has returned 18.78%. That puts FXH better performer ahead so far this year.

Which ETF is attracting more investor money: LGHT or FXH?

Year-to-date, the LGHT ETF saw -$1M in flows, compared to +$33M for FXH.

Which ETF is more volatile: LGHT or FXH?

Over the past year, LGHT had a volatility of 26.13%, while FXH experienced 15.45%.

Which ETF is bigger: LGHT or FXH?

As of October 16, 2026, LGHT holds $2.53 M in assets under management (AUM), while FXH manages $1.14 B.

What sectors do the LGHT and FXH ETFs invest in?

LGHT leans toward sectors like Healthcare. Meanwhile, FXH focuses on Healthcare.

What are the top holdings of the LGHT ETF and FXH ETF?

LGHT top holdings include Moderna, Inc., Veeva Systems, Inc. and ResMed, Inc.. FXH holds in its top three: Regeneron Pharmaceuticals, Inc., Pfizer Inc. and Natera, Inc..

Which ETF is more diversified: LGHT or FXH?

LGHT holds 30 securities with 90.56% of its assets in the top 15. FXH has 72 securities and a top 15 weight of 35.47%.

Advertisement
Advertisement
Advertisement
New Report

ETFs’ Next Act: From Access to Selection

With 1,790 new products launched by July 2026, choosing is harder than ever. Our Global ETF Survey 2026, built on 620 professional investors and allocators, shows how active, fixed income, options-based and thematic ETFs are reshaping fund selection.

Global ETF Survey 2026